| IV-053 Tamara van Donge Middle-out physiologically-based pharmacokinetic modeling to support pediatric dosing recommendation for alectinib, an ALK tyrosine kinase receptor inhibitor Thursday 15:00-16:30 |
| IV-054 Tamara van Donge Population PK modeling of Vamikibart in aqueous humor, an anti-IL-6 monoclonal antibody, in patients with diabetic and uveitic macular edema Thursday 15:00-16:30 |
